Mustang Bio, Inc. (MBIO)
0.5412
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Mustang Bio Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.2267 |
| September 30, 2024 | -0.1136 |
| June 30, 2024 | -0.1303 |
| March 31, 2024 | -0.4849 |
| December 31, 2023 | 20.31 |
| September 30, 2023 | 0.6423 |
| June 30, 2023 | 0.1931 |
| March 31, 2023 | 1.056 |
| December 31, 2022 | 0.6782 |
| September 30, 2022 | 0.4863 |
| June 30, 2022 | 0.3538 |
| March 31, 2022 | 0.2973 |
| December 31, 2021 | 0.0181 |
| September 30, 2021 | 0.0171 |
| June 30, 2021 | 0.016 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.0162 |
| December 31, 2020 | 0.0226 |
| September 30, 2020 | 0.03 |
| June 30, 2020 | 0.2297 |
| March 31, 2020 | 0.3516 |
| December 31, 2019 | 0.3006 |
| September 30, 2019 | 0.2455 |
| June 30, 2019 | 0.2095 |
| March 31, 2019 | 0.5173 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.0021 |
| March 31, 2017 | 0.0004 |
| December 31, 2016 | 0.0132 |
| September 30, 2016 | 1.483 |
| June 30, 2016 | -0.7903 |
| March 31, 2016 | -0.8251 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 15.61M |
| Total Liabilities (Quarterly) | 8.068M |
| Shareholders Equity (Quarterly) | 7.545M |
| Current Ratio | 1.972 |